6744.TWO Feng Chi Biotech Corp.

Healthcare Biotechnology Taiwan OTC Exchange
12.25 TWD
Close of Nov 6, 2026
11.05 18.62
Market cap
TWD 189M
P/E
18.8x
P/B
0.83x
ROE
6.0%
Dividend yield
7.76%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6744.TWO undervalued?

Graham number
Price12.25
Graham value14.67
Discount16.5%

6744.TWO trades 16.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Feng Chi Biotech Corp. fundamental analysis

No fundamental analysis for Feng Chi Biotech Corp. yet.

Feng Chi Biotech Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Feng Chi Biotech Corp.

Feng Chi Biotech Corp. engages in the wholesale and retail of medical devices and precision instruments and biotechnology services in Taiwan and internationally. The company provides preimplantation genetic testing, prenatal testing, precision medicine, newborn screening, food/pharmaceutical microbiological testing, and medical translational research services, as well as infectious disease detection services. It also distributes various genetic and medical testing services. …

Full company profile